Cancer dominates newly revealed list of drugs under evaluation at EMA
This article was originally published in SRA
Executive Summary
A total of 76 medicines for human use are under evaluation at the European Medicines Agency, of which 18 are for cancer indications, five for diabetes and four for respiratory tract diseases, the agency has disclosed as part of its drive for transparency1.